Quantity | = | Concentration | x | Volume | x | Molecular Weight |
---|---|---|---|---|---|---|
= | x | x |
1) Click the Molarity Calculation Cart® button.
2) Specify the Concentration and Volume of your desired Molarity.
3) Click Calculate.
4) Your desired Quantity will be calculated and will be put under Quantity: (only for mg)
5) Click Add to Cart and then Proceed to checkout to complete the order. You will receive the quantity as you ordered as solvent-free form.
Alert: If you want to make a solution with a solvent (such DMSO), please add instructions in the notes section (such as 10 nM/1 mL in DMSO) and we will pack and deliver the product as a solution (such as 10 nM solution in 1 mL DMSO). If the product cannot be dissolved in DMSO or you would like to specify your own preferred solvent, please add detailed instructions in the notes section. All solutions must be shipped with an ice bag, costing an additional fee of $20 for S&H.
AOB36447
CAS No: 1416992-39-6
Chemical Name: Sodium (2S)-2-((S)-2-(((benzyloxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-(2-oxopyrrolidin-3-yl)propane-1-sulfonate
AOBIOUS launched this product in 2018
CITATIONS - Publications That Use AOBIOUS Product
Warning: Last items in stock!
Availability date:
Molecular Formula | C21H30N3NaO8S |
Molecular Weight | 507.53 |
CAS Numbers | 1416992-39-6 |
Storage Condition | 0°C (short term), -20°C (long term), desiccated |
Solubility | H2O |
Purity | 98% by HPLC |
Synonym | GC376; GC-376; GC 376; GC376 sodium |
IUPAC/Chemical Name | sodium (2S)-2-((S)-2-(((benzyloxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-(2-oxopyrrolidin-3-yl)propane-1-sulfonate |
InChl Key | BSPJDKCMFIPBAW-JPBGFCRCSA-M |
InChl Code | InChI=1S/C21H31N3O8S.Na/c1-13(2)10-16(24-21(28)32-12-14-6-4-3-5-7-14)19(26)23-17(20(27)33(29,30)31)11-15-8-9-22-18(15)25;/h3-7,13,15-17,20,27H,8-12H2,1-2H3,(H,22,25)(H,23,26)(H,24,28)(H,29,30,31);/q;+1/p-1/t15?,16-,17-,20?;/m0./s1 |
SMILES Code | O=S(C(O)[C@@H](NC([C@@H](NC(OCC1=CC=CC=C1)=O)CC(C)C)=O)CC2C(NCC2)=O)([O-])=O.[Na+] |
References | 1) Pedersen NC, et al. Efficacy of a 3C-like protease inhibitor in treating various forms of acquired feline infectious peritonitis. J Feline Med Surg. 2018 Apr;20(4):378-392. 2) Takahashi D, et al. Structural andinhibitor studies of norovirus 3C-like proteases. Virus Res. 2013 Dec 26;178(2):437-44. |
Novel 3C-like protease inhibitor for treating various forms of acquired feline infectious peritonitis
References (click to read) :
1) NO CLAIM TO CURE OR DRUG READINESS
2) An in-depth analysis of the UC Davis GC376 field study
3) Journal of Feline Medicine and Surgery 2018, Vol. 20(4) 378–392